Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Pontifax Management III G.P. (2011) Ltd.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
40,000 $0 40,000
(Indirect)
View
2019-05-29
Option Award
2019-05-29
5:15 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management 4 G.P. (2015) Ltd.
Pontifax IV GP L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax (Israel) IV L.P.
Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
40,000 $0 40,000
(Indirect)
View
2018-06-15
Option Award
2018-06-19
6:22 pm
N/A
2028-06-15
Eloxx Pharmaceuticals Inc. ELOX Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
80,000 $0 80,000
(Indirect)
View
2017-12-19
Ownership
2017-12-29
6:11 pm
N/A
N/A
Eloxx Pharmaceuticals Inc. SVOND Pontifax Management III G.P. (2011) Ltd.
Pontifax Management Fund III L.P.
Pontifax (Cayman) III L.P.
Pontifax (Israel) III L.P.
10% Owner
0 $0 7,188,186
(Indirect)
View